These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26053729)

  • 21.
    Kopp J; Kopp D; Bernhardt E; Manka L; Beck A; Gerullis H; Karakiewicz P; Schoerner W; Hammerer P; Schiffmann J
    World J Urol; 2020 Dec; 38(12):3085-3090. PubMed ID: 32103332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 68Ga-PSMA-11 PET/CT in Newly Diagnosed Prostate Adenocarcinoma.
    Ergül N; Yilmaz Güneş B; Yücetaş U; Toktaş MG; Çermik TF
    Clin Nucl Med; 2018 Dec; 43(12):e422-e427. PubMed ID: 30273204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rectal Carcinoma on 68Ga-PSMA PET/CT.
    Huang YT; Fong W; Thomas P
    Clin Nucl Med; 2016 Mar; 41(3):e167-8. PubMed ID: 26571447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 68Ga-PSMA-11 PET/MR Can Be False Positive in Normal Prostatic Tissue.
    Ferraro DA; Rupp NJ; Donati OF; Messerli M; Eberli D; Burger IA
    Clin Nucl Med; 2019 Apr; 44(4):e291-e293. PubMed ID: 30688746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of
    Schwenck J; Rempp H; Reischl G; Kruck S; Stenzl A; Nikolaou K; Pfannenberg C; la Fougère C
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):92-101. PubMed ID: 27557844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (68)Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
    Ceci F; Uprimny C; Nilica B; Geraldo L; Kendler D; Kroiss A; Bektic J; Horninger W; Lukas P; Decristoforo C; Castellucci P; Fanti S; Virgolini IJ
    Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1284-94. PubMed ID: 25975367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subacute Cortical Infarct Showing Uptake on 68Ga-PSMA PET/CT.
    Chan M; Hsiao E
    Clin Nucl Med; 2017 Feb; 42(2):110-111. PubMed ID: 27997426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET/CT imaging.
    Demirci E; Sahin OE; Ocak M; Akovali B; Nematyazar J; Kabasakal L
    Nucl Med Commun; 2016 Nov; 37(11):1169-79. PubMed ID: 27333090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 68Ga-PSMA-HBED-CC-Avid Synchronous Urinary Bladder Paraganglioma in a Patient With Metastatic Prostate Carcinoma.
    Parihar AS; Vadi SK; Mittal BR; Kumar R; Bal A; Singh SK
    Clin Nucl Med; 2018 Sep; 43(9):e329-e330. PubMed ID: 29916916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Marked Response to 177Lu Prostate-Specific Membrane Antigen Treatment in Patient With Metastatic Prostate Cancer.
    Soydal C; Ozkan E; Akyurek S; Kucuk NO
    Clin Nucl Med; 2016 Feb; 41(2):159-60. PubMed ID: 26505861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biphasic ⁶⁸Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma.
    Sahlmann CO; Meller B; Bouter C; Ritter CO; Ströbel P; Lotz J; Trojan L; Meller J; Hijazi S
    Eur J Nucl Med Mol Imaging; 2016 May; 43(5):898-905. PubMed ID: 26563122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of failure after radical prostatectomy in prostate cancer - implications for radiation therapy planning after
    Schiller K; Sauter K; Dewes S; Eiber M; Maurer T; Gschwend J; Combs SE; Habl G
    Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1656-1662. PubMed ID: 28646463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. De Novo Metastatic Prostate Cancer Presenting With Atypical Lower-Limb Skeletal Metastases Detected on 68 Ga-PSMA PET/CT.
    Yip A; Yap J
    Clin Nucl Med; 2024 Jul; 49(7):e346-e350. PubMed ID: 38687004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modelling Study with an Interactive Model Assessing the Cost-effectiveness of
    Scholte M; Barentsz JO; Sedelaar JPM; Gotthardt M; Grutters JPC; Rovers MM
    Eur Urol Focus; 2020 Sep; 6(5):967-974. PubMed ID: 30826284
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Iravani A; Hofman MS; Mulcahy T; Williams S; Murphy D; Parameswaran BK; Hicks RJ
    Cancer Imaging; 2017 Dec; 17(1):31. PubMed ID: 29268784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 18F-FDG, 68Ga-DOTATATE and 68Ga-PSMA Positive Metastatic Large Cell Neuroendocrine Prostate Tumor.
    Acar E; Kaya GÇ
    Clin Nucl Med; 2019 Jan; 44(1):53-54. PubMed ID: 30325820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone Flare to Androgen Deprivation Therapy in Metastatic, Hormone-Sensitive Prostate Cancer on 68Ga-Prostate-Specific Membrane Antigen PET/CT.
    Zacho HD; Petersen LJ
    Clin Nucl Med; 2018 Nov; 43(11):e404-e406. PubMed ID: 30222680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PET/MRI with a 68Ga-PSMA ligand for the detection of prostate cancer.
    Afshar-Oromieh A; Haberkorn U; Hadaschik B; Habl G; Eder M; Eisenhut M; Schlemmer HP; Roethke MC
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1629-30. PubMed ID: 23817686
    [No Abstract]   [Full Text] [Related]  

  • 39.
    von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
    Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uncommon Penio-Scrotal Metastases of Prostate Cancer Detected on 68Ga PSMA PET/CT.
    Seniaray N; Verma R; Khanna S; Belho E; Malik D
    Clin Nucl Med; 2019 May; 44(5):424-425. PubMed ID: 30829866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.